This paper will focus on the interchange between the critical commercial and medical functions and the decisions they can make or change as a result of input from key sources of intelligence and experience. Case studies which illustrate the interactive role marketing inteligence can play will be utilised. In particular the experience of drawing on a wide range of disciplines into a go/no go decision for a new chronic medicine will be reviewed, and the inclusion of marketing research approaches, as a health economics vehicle across chronic and acute areas will be described. The marketing research involvement in all of these decisions will be reviewed in terms of the variety of its input. This will be sharply differentiated from its output examples of which will be a clinical trial design; decisions not to pursue a cost benefit study; and definition of the information requirements from regulatory authorities to achieve alternative price scenarios.
The paradox of 'the new qualitative research'
Catalogue: Seminar 1986: Qualitative Methods Of Research
Authors: Stephen Wells, Tony Lunn
June 15, 1986
The secrets of neuromarketing
Catalogue: Latin America 2008
Authors: Alejandra Ruiz-Contreras, Javier Cervantes, Oscar Prospero-Garcia, Philipp Hillenbrand
May 13, 2008
Innovation: Return to reality
Catalogue: Innovate 2010: Innovation Detonation
Authors: Michel Ten Donkelaar, Richard Bordenave
Companies: BVA Group, Kraft Heinz Company
November 16, 2010
- This could also be of interest